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for pregnancies complicated by placenta praevia (2.1% versus 0.5%, respectively; OR 3.9; 95% CI, 3.5-4.3).
1
The effect of severe forms of endometriosis and deep lesions on the incidence of placenta praevia A dose-response relation of endometriosis severity with risk of placenta praevia has been observed. In the above Danish national cohort, pre-conceptional surgery considered as a surrogate marker of more severe endometriosis, was associated with a further increase in risk of placenta praevia (OR, 5.5; 95% CI, 4.6-6.5). 1 According to a Japanese cohort study conducted on women who conceived with assisted reproduction techniques (ART), the OR of placenta praevia in women with all endometriosis forms was 15.1 (95% CI, 4.4-61.7), but increased up to 39.8 (95% CI, 10.1-189.1) when only patients with severe endometriosis were considered. 4 The specific effect attributable to deep endometriosis was firstly investigated on a large series of women with different disease forms who achieved a singleton pregnancy after natural attempts. The frequency of placenta praevia was 7.6% in 150 patients with rectovaginal lesions, but between 0 and 2.4% in 269 women with peritoneal and/or ovarian forms. 5 Compared with the latter patients, those with rectovaginal endometriosis had an almost six-fold increase in risk (OR 5.8; 95% CI 1.5-22.0). An increased prevalence of placenta praevia in association with deep endometriotic lesions within the posterior pelvic compartment was also reported in a subsequent cohort (17.1% (7/41) in women with ≥ 2cm nodules versus 0.3% (1/300) in women without a diagnosis of endometriosis (OR 61.6; 95% CI 7.4-515.5)). 6 One further series did not however, find a difference between deep and more superficial endometriosis in the rate of placenta praevia. 7 Several pathogenic
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hypotheses have been formulated regarding the mechanisms underlying a possible association between deep endometriosis and placenta praevia. 1, 5, 6 The additional effect of IVF, twinning, and blastocyst transfer on the incidence of placenta praevia An almost fourfold increase in risk of placenta praevia was observed in singleton pregnancies after ART compared with those conceived naturally (RR, 3.7; 95% CI, 2.7-5.2). 8 A further systematic review, restricted to dichorionic twin pregnancies, showed an almost threefold increase in the risk of placenta praevia in conceptions achieved with ART compared with those achieved with natural attempts (RR 2.9; 95% CI, 1.5-5.9). 9 Therefore, ART appears to confer an increase in risk probably related to the manipulation involved in the in-vitro fertilisation and embryo transfer (IVF) technology, beyond the already observed increase in risk associated with twinning per se.
Among women achieving a conception with ART, Healy et al. were the first to report a significantly increased risk of placenta praevia in patients with endometriosis compared with those without the disease (OR 1.7; 95% CI, 1.2-2.4). 10 In the large cohort study conducted by Rombauts et al., endometriosis was shown to be an independent risk factor for placenta praevia (OR 2.0; 95% CI, 1.2-3.3). 11 In the population-based Japanese study, 2 the OR of placenta praevia in women with endometriosis was almost halved (from 6.4 to 3.3)
when only women without infertility treatment were considered. Other investigators observed rates of placenta praevia ranging from 6.0% to 20.0% in women with endometriosis, but from 0.3% to 1.3% in women without the disease. 4, 6, 12 Unfortunately, with one exception, 6 withinstudy comparisons between women achieving conception naturally and with IVF are lacking.
The disease-specific risk of placenta praevia in women with endometriosis may be amplified by fertility treatments. This is particularly relevant, as the advent of oocyte donation programs has greatly increased the probability of pregnancy even in women with the most distorted anatomic condition and independently of previous ovarian surgical injury.
The potential obstetrical consequences of placenta praevia in association with deep endometriosis Placenta praevia, especially when morbidly adherent, may cause postpartum haemorrhage and require emergency caesarean hysterectomy. However, in patients with extensively infiltrating endometriosis, and especially in those who underwent previous complex procedures such as colorectal resection and ureteral-bladder re-implantation, even the access to the abdominal cavity may be cumbersome. The development of the utero-vesical space in order to incise the lower uterine segment may reveal impracticable in cases of bladder endometriosis, which generally causes firm adhesion to the uterine anterior wall and fundus.
The pelvis may be obliterated in women with rectovaginal lesions, with the rectosigmoid stuck to the posterior uterine wall. Complications during caesarean section, including haemorrhage and bladder injuries, were significantly more frequent in women with deep posterior compartment endometriosis than in those without endometriosis. 6 In cases of uncontrolled haemorrhage due to placenta praevia, an emergency caesarean hysterectomy will be more technically demanding, potentially threatening maternal safety. In fact, placenta previa requires total rather than sub-total hysterectomy, but the bleeding lower uterine segment is precisely the anatomical site most severely involved by infiltrating endometriotic lesions and dense adhesions with surrounding organs. In addition, surgery must be performed rapidly in order to limit blood loss.
Can we reduce the non-specific risk of placenta praevia attributable to ART? In an IVF setting, elective single embryo transfer (eSET) is mandatory in cases of severe and deep endometriosis, as multiplicity would translate not only in an increased risk of prematurity, but also of placenta praevia. The indication to eSET is even more important when undergoing oocyte donation programs. In particular, transfer at blastocyst stage of two embryos obtained with oocyte donation should never be contemplated. Moreover, albeit evidence is not yet conclusive, physicians may consider cleavage rather than blastocyst transfer, and could implement freeze-all policies. 11 Indeed, recent data suggests an increased likelihood of placenta praevia associated with transfer of a day 5 embryo and a lower risk in women undergoing elective frozen embryo transfer in a natural cycle.
11
When pregnant women with rectovaginal lesions are diagnosed with placenta praevia, they should be referred to tertiary care centres with experience in both deep endometriosis and surgically complex obstetrical cases. To limit the risk of major intra-and postoperative complications, elective caesarean sections must be undertaken exclusively in hospitals with a blood bank, an interventional radiology unit, and availability of skilled obstetricians, colorectal surgeons, and urologists.
Information regarding the increased risk of placenta praevia should be disseminated among gynaecologists in charge of women with severe endometriosis and particularly among those providing ART. Both clinicians should also understand that the surgical implications of a placenta praevia in these women are different from those in the general pregnant population, and that a caesarean hysterectomy may pose the woman's safety at risk. A strict collaboration between the caring physicians, the personnel performing IVF, and the obstetricians that follow the pregnancy and carry out the delivery is mandatory. In fact, the objective of the ART process in this particular group of patients is not only a healthy singleton, but also a healthy mother after delivery. The short-term goal of maximising
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reproductive success per embryo transfer, which is rewarding for both doctors and patients, appears here particularly short-sighted. In women with deep infiltrating endometriosis, the safety of the ART procedure is certainly no less important than its efficacy. Providers of IVF treatments must minimise late-pregnancy complications and safeguard the long-term health of the mother in addition to that of the baby. Incidentally, doctors who have to manage the consequences of multiple embryo replacement generally are not those who performed the IVF procedure.
Women must be allowed to make informed choices regarding their health based on their priorities and preferences. Thus, counselling patients is of utmost importance. The possibility of developing a placenta praevia and the potential obstetrical consequences should be described in detail to women with severe and deep endometriosis, whether operated or not.
They should also know that IVF further increases the risk, and should be strongly invited to undergo exclusively eSET independently of age, ovarian reserve status, overall burden of treatment, and costs. Once adequately informed and fully aware, women may choose differently; some may decide to take the risk, but others may consider refraining from fertility treatments. It is their decision, not ours, and once pregnant they cannot turn back time.
